EUVIMEDEUVIMED entdecken
Crossref

Optimizing antibody stability and efficacy in CD47- SIRPα inhibition via computational approaches

Kapil Laddha, M Elizabeth Sobhia

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-11037-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Kapil Laddha und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S.A.S Nagar, Mohali, Punjab, 160062, India. Hauptthemen laut MEDLINE: CD47 Antigen, Receptors, Immunologic, Antigens, Differentiation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD47, a cell surface protein, serves as a "don't eat me" signal that prevents immune cells from engulfing healthy cells upon its interaction with SIRPα. Cancer cells exploit this mechanism by overexpressing CD47 to evade immune destruction. Blocking the interaction between CD47 and its receptor, SIRPα, is a promising therapeutic strategy. Targeting the interactions between these surface proteins with small molecules is quite challenging, and on the other hand, antibodies offer potential. However, the interactions between antigen (CD47) and antibody (B6H12.2) play a crucial role in this scenario, and increasing the affinity by mutating the interacting residues might impact the inclination and effectiveness of the antibody towards antigen. Thus, this study focuses on designing antibodies with increased affinity and stability towards the antigen compared to the wild-type. Residual scanning calculations were performed to mutate the interacting as well as the hydrophobic residues of the antibody and affinity was assessed. Computational approaches, including antigen-antibody docking studies and molecular dynamics simulations, were employed to evaluate the affinity, stability and therapeutic potential of these modified antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD47 AntigenReceptors, ImmunologicAntigens, DifferentiationHumansMolecular Dynamics SimulationMolecular Docking SimulationProtein BindingProtein Stability

Stichwörter der Autor:innen

Antigen–antibodyAntigen–antibody dockingCD47-SIRPαMolecular dynamics

Substanzen

CD47 AntigenReceptors, ImmunologicSIRPA protein, humanAntigens, DifferentiationCD47 protein, human

Autor:innen und Institutionen

  • Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S.A.S Nagar, Mohali, Punjab, 160062, India.
  • Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, S.A.S Nagar, Mohali, Punjab, 160062, India. mesophia@niper.ac.in.

Zitieren

APA

Laddha, K., & Sobhia, M. E. (2025). Optimizing antibody stability and efficacy in CD47- SIRPα inhibition via computational approaches. Molecular Diversity. https://doi.org/10.1007/s11030-024-11037-x

Vancouver

Laddha K, Sobhia ME. Optimizing antibody stability and efficacy in CD47- SIRPα inhibition via computational approaches. Molecular Diversity. 2025. doi:10.1007/s11030-024-11037-x

BibTeX
@article{Laddha2025,
  author = {Laddha, Kapil and Sobhia, M Elizabeth},
  title = {Optimizing antibody stability and efficacy in CD47- SIRPα inhibition via computational approaches},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-11037-x}
}
Kostenlos starten →